Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia
NCT07750730Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Aug 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in trigeminal neuralgia (TN) (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Brief Pain Inventory-Facial total score at 8 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT07750730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07750730.